Page last updated: 2024-10-28

hexoprenaline and Chronic Disease

hexoprenaline has been researched along with Chronic Disease in 3 studies

Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"The bronchodilator effects of aerosols of hexoprenaline (200 microgram and 400 microgram), and salbutamol (200 microgram) were compared in 15 patients with asthma, and nine patients with chronic bronchitis."9.04Bronchodilator effect of hexoprenaline aerosol in bronchial asthma and chronic bronchitis. ( Evers, R; Harris, M; Jenne, H; McMiken, D; Schonell, M, 1977)
"The bronchodilator effects of aerosols of hexoprenaline (200 microgram and 400 microgram), and salbutamol (200 microgram) were compared in 15 patients with asthma, and nine patients with chronic bronchitis."5.04Bronchodilator effect of hexoprenaline aerosol in bronchial asthma and chronic bronchitis. ( Evers, R; Harris, M; Jenne, H; McMiken, D; Schonell, M, 1977)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaik, G1
Bonelli, J1
Magometschnigg, D1
Pittner, H1
Radda, TM1
Rameis, H1
Cholevas, M1
Economidis, D1
Lefkos, N1
Sakamadis, G1
Concouris, L1
Schonell, M1
Harris, M1
McMiken, D1
Jenne, H1
Evers, R1

Trials

2 trials available for hexoprenaline and Chronic Disease

ArticleYear
[Bronchospasmolysis in chronic obstructive respiratory tract disease. Clinico-pathological studies using theophylline-ethylenediamine, diprophylline, and hexoprenaline].
    Wiener medizinische Wochenschrift (1946), 1977, Aug-15, Volume: 127, Issue:15

    Topics: Airway Obstruction; Aminophylline; Bronchial Spasm; Chronic Disease; Ethylenediamines; Female; Fenot

1977
Bronchodilator effect of hexoprenaline aerosol in bronchial asthma and chronic bronchitis.
    The Medical journal of Australia, 1977, Dec-17, Volume: 2, Issue:25

    Topics: Adult; Aerosols; Aged; Albuterol; Asthma; Bronchi; Bronchitis; Chronic Disease; Clinical Trials as T

1977

Other Studies

1 other study available for hexoprenaline and Chronic Disease

ArticleYear
[Effect of hexoprenaline on respiratory and heart functions in chronic obstructive lung disease].
    Wiener medizinische Wochenschrift. Supplement, 1978, Volume: 50

    Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Electrocardiography; Female; Heart; Heart Functi

1978